Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

[1]  E. Wynder,et al.  Nonsteroidal antiinflammatory drugs and colorectal cancer , 1994, Cancer.

[2]  N. Camp,et al.  Classification tree analysis: a statistical tool to investigate risk factor interactions with an example for colon cancer (United States) , 2002, Cancer Causes & Control.

[3]  R. Millikan,et al.  Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. , 2005, American journal of epidemiology.

[4]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[5]  E. Wynder,et al.  Analgesic use and colorectal cancer. , 1995, Preventive Medicine.

[6]  J. Potter,et al.  Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use. , 2006, Cancer research.

[7]  A. Folsom,et al.  Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  L. Rosenberg.  Nonsteroidal anti-inflammatory drugs and cancer. , 1995, Preventive medicine.

[9]  L F Watson,et al.  Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.

[10]  A. Tenenbaum,et al.  Long-term diuretic therapy in patients with coronary disease: increased colon cancer-related mortality over a 5-year follow-up , 2001, Journal of Human Hypertension.

[11]  D. Brewster,et al.  Reliability of cancer registration data in Scotland, 1997. , 2002, European journal of cancer.

[12]  C. Muir,et al.  Registration of colorectal cancer in Scotland: an assessment of data accuracy based on review of medical records. , 1995, Public health.

[13]  C. la Vecchia,et al.  Aspirin and colorectal cancer. , 1997, British Journal of Cancer.

[14]  J. Meyerhardt,et al.  Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. , 2005, JAMA.

[15]  R. Lancashire,et al.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.

[16]  J. Buring,et al.  Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. , 2006, The American journal of medicine.

[17]  D. Martinez-Hernandez,et al.  Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[18]  S. Shapiro,et al.  NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease , 2000, Cancer Causes & Control.

[19]  S. Shapiro,et al.  Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma , 1998, Cancer.

[20]  C. Lindley,et al.  Use of NSAIDs for the Chemoprevention of Colorectal Cancer , 2003, The Annals of pharmacotherapy.

[21]  J. Manson,et al.  Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study , 1998, Annals of Internal Medicine.

[22]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[23]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[24]  S. Solomon,et al.  Celecoxib for the prevention of colorectal adenomatous polyps. , 2006, The New England journal of medicine.

[25]  B. Graubard,et al.  Aspirin use and mortality from cancer in a prospective cohort study. , 2004, Anticancer research.

[26]  Jeannette Bigler,et al.  Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics , 2006, Nature Reviews Cancer.

[27]  R. Wolff,et al.  PPARγ and Colon and Rectal Cancer: Associations with Specific Tumor Mutations, Aspirin, Ibuprofen and Insulin-Related Genes (United States) , 2006, Cancer Causes & Control.

[28]  P. Whelton,et al.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.

[29]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[30]  H. Jick,et al.  Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.

[31]  A. Barkun,et al.  The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence. , 2003, Gastroenterology.

[32]  J. Hanley,et al.  Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing , 1999, British Journal of Cancer.

[33]  W. Ray,et al.  Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. , 1999, Archives of internal medicine.

[34]  J. Little,et al.  Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. , 2003, Gastroenterology.

[35]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[36]  M. Thun,et al.  Risk factors for fatal colon cancer in a large prospective study. , 1992, Journal of the National Cancer Institute.

[37]  K. Seibert,et al.  Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.

[38]  A. Rubinstein.  Approaches and opportunities in colon-specific drug delivery. , 1995, Critical reviews in therapeutic drug carrier systems.

[39]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[40]  D. Ahnen,et al.  Adenomatous Polyps of the Colon , 2006 .

[41]  N. Petrelli,et al.  Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.

[42]  C. Mel Wilcox,et al.  Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia , 1996, Digestive Diseases and Sciences.

[43]  A. Swerdlow,et al.  Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. , 1992, British Journal of Cancer.

[44]  J. Potter,et al.  Drugs and colon cancer , 1998, Pharmacoepidemiology and drug safety.

[45]  T. Sugimura,et al.  Suppression of azoxymethane‐induced colon cancer development in rats by a cyclooxygenase‐1 selective inhibitor, mofezolac , 2006, Cancer science.

[46]  Gianni Tognoni,et al.  Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.

[47]  G. Beck,et al.  A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.

[48]  D. Ashby,et al.  Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. , 2002, Gastroenterology.

[49]  N. Vickers,et al.  Reliability of data of the Thames cancer registry on 673 cases of colorectal cancer: effect of the registration process. , 1995, Quality in health care : QHC.

[50]  S. Larsson,et al.  Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden , 2006, British Journal of Cancer.

[51]  S. Solomon,et al.  Celecoxib for the prevention of sporadic colorectal adenomas. , 2006, The New England journal of medicine.

[52]  J. Baron,et al.  A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. , 2006, Gastroenterology.

[53]  A. Paganini-Hill.  Aspirin and colorectal cancer: the Leisure World cohort revisited. , 1995, Preventive medicine.

[54]  B. Henderson,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[55]  S. Kozuka,et al.  Premalignancy of the mucosal polyp in the large intestine: II. Estimation of the periods required for malignant transformation of mucosal polyps , 1975, Diseases of the colon and rectum.

[56]  M. Vatn,et al.  Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. , 1999, Scandinavian journal of gastroenterology.

[57]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[58]  S. Hernández-Díaz,et al.  Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. , 2001, British journal of clinical pharmacology.

[59]  S. Gallus,et al.  Aspirin and cancer risk: an updated quantitative review to 2005 , 2006, Cancer Causes & Control.

[60]  B. Henderson,et al.  Aspirin use and incidence of large-bowel cancer in a California retirement community. , 1991, Journal of the National Cancer Institute.

[61]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[62]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[63]  J. Reguła,et al.  Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. , 2006, The New England journal of medicine.

[64]  R. Millikan,et al.  COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States) , 2006, Cancer Causes & Control.

[65]  D. Lawlor,et al.  Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? , 2004, The Lancet.

[66]  G. Kelloff,et al.  Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. , 1993, Carcinogenesis.

[67]  P. Remington,et al.  Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[68]  S. H. Brown,et al.  Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. , 1994, Archives of internal medicine.

[69]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[70]  M. Taketo.  Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). , 1998, Journal of the National Cancer Institute.

[71]  Fang Sun,et al.  [Nonsteroidal anti-inflammatory drugs and the risk of polyposis, colon carcinoma and rectal carcinoma]. , 2002, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[72]  S. Solomon,et al.  Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas , 2006, Circulation.

[73]  K. Anderson,et al.  Lifestyle factors and Ki-ras mutations in colon cancer tumors. , 2001, Mutation research.

[74]  S. Neuhausen,et al.  Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[75]  Susan Halabi,et al.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. , 2003, The New England journal of medicine.

[76]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[77]  R. Langer,et al.  The association between aspirin use and the incidence of colorectal cancer in women. , 2006, American journal of epidemiology.

[78]  S. Shapiro,et al.  A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.

[79]  D. Alberts,et al.  Colorectal Adenomas , 2004, Clinical Cancer Research.

[80]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[81]  A. Neugut,et al.  Association between coronary heart disease and cancers of the breast, prostate, and colon. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.